| Authors: |
Bar J; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada. Electronic address: bar.jair@gmail.com., Ding K; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada., Zhao H; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Han L; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada., Laurie SA; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada., Seymour L; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada., Addison CL; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Ontario, Canada., Shepherd FA; University Health Network, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Goss GD; Division of Medical Oncology, The Ottawa Hospital Cancer Center, Ottawa, Ontario, Canada., Dimitroulakos J; Centre for Cancer Therapeutics the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Ontario, Canada., Bradbury PA; NCIC Clinical Trials Group and Queen's University, Kingston, Ontario, Canada. |
